Parallax Volatility Advisers’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,300
Closed -$1.24K 1895
2023
Q4
$1.24K Hold
1,300
﹤0.01% 2089
2023
Q3
$1.4K Hold
1,300
﹤0.01% 2199
2023
Q2
$1.17K Hold
1,300
﹤0.01% 2287
2023
Q1
$1.1K Sell
1,300
-9,300
-88% -$10.2K ﹤0.01% 2600
2022
Q4
$9.86K Buy
+10,600
New +$14.1K ﹤0.01% 2565
2022
Q3
Sell
-7,600
Closed -$14K 3088
2022
Q2
$14K Buy
+7,600
New +$20.2K ﹤0.01% 2628

Other funds holding CLOV

Parallax Volatility Advisers's CLOV Position: Q1 2025 in Review

Parallax Volatility Advisers sold out of Clover Health Investments (CLOV) in Q1 2025, closing a stake of 19,855 shares — an estimated $62.5K sold.

Parallax Volatility Advisers first reported a position in CLOV in Q2 2022 and held it in 8 quarters. The position peaked at $182K in Q2 2023. 202 funds tracked by Wall St. Rank hold CLOV as of Q1 2025.

  • Parallax Volatility Advisers reported no remaining Clover Health Investments position as of Q1 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 19,855 Clover Health Investments shares in Q1 2025, an estimated $62.5K.
  • Parallax Volatility Advisers first reported a position in Clover Health Investments in Q2 2022 and held it in 8 quarters.
  • Parallax Volatility Advisers's Clover Health Investments position peaked at $182K in Q2 2023.
  • 202 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2025.

Based on Parallax Volatility Advisers's 13F filing for Q1 2025, filed 15 May 2025.